SCHEMBL5160240

SCHEMBL5160240

O=c1[nH]nc(CNc2ccc(O)cc2)c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 1.00
▸ KMT2A Q03164 3/20 1.00
▸ GAA P10253 2/20 1.00
▸ HTT P42858 2/20 1.00
▸ KDM4E B2RXH2 2/20 1.00
▸ MEN1 O00255 1/20 1.00
▸ ALDH1A1 P00352 1/20 1.00
▸ THRB P10828 1/20 1.00
▸ RECQL P46063 1/20 1.00
▸ BLM P54132 1/20 1.00
▸ SMN1; SMN2 Q16637 3/20 0.65
▸ LMNA P02545 2/20 0.57
▸ HIF1A Q16665 1/20 0.55
▸ PRMT5 O14744 1/20 0.53
▸ POLB P06746 2/20 0.51
▸ PARP1 P09874 3/20 0.50
▸ AR P10275 2/20 0.50
▸ BRD4 O60885 1/20 0.48
▸ ENPP1 P22413 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165966 0.88 MAPT (0.78) MAPTKMT2AGAAHTTKDM4E
SCHEMBL5160111 0.86 MAPT (0.75) MAPTKMT2AGAAHTTKDM4E
SCHEMBL5164835 0.82 MAPT (0.77) MAPTKMT2AGAAHTTKDM4E
SCHEMBL5161752 0.82 MAPT (1.00) MAPTKMT2AGAAHTTKDM4E
SCHEMBL5162135 0.81 MAPT (0.68) MAPTKMT2AGAAHTTKDM4E
SCHEMBL5165083 0.79 HTT (1.00) MAPTKMT2AGAAHTTKDM4E
SCHEMBL6281157 0.78 MAPT (0.64) MAPTKMT2AGAAHTTKDM4E
SCHEMBL12955526 0.78 AR (0.77) MAPTKMT2AGAAHTTKDM4E
SCHEMBL6326092 0.76 MAPT (0.61) MAPTKMT2AGAAHTTKDM4E
SCHEMBL13858810 0.75 KDM4E (0.66) MAPTKMT2AGAAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1231982-B1 USE OF PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ABBOTT GMBH & CO KG (DE) 2007-03-21 — — EP disclosed
US-6903098-B1 Use of phthalazine derivatives ABBOTT GMBH & CO. (DE) 2005-06-07 — — US disclosed
Send feedback